| Nabil Jazayerli, MD | |
|
715 Williams St, Cumberland, MD 21502-6390 | |
| (301) 759-3817 | |
| (301) 759-3286 |
| Full Name | Nabil Jazayerli |
|---|---|
| Gender | Male |
| Speciality | Internal Medicine - Cardiovascular Disease |
| Location | 715 Williams St, Cumberland, Maryland |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1134126360 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RC0000X | Internal Medicine - Cardiovascular Disease | D40736 (Maryland) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Nabil Jazayerli, MD Po Box 1692, Cumberland, MD 21501-1692 Ph: (301) 759-3817 | Nabil Jazayerli, MD 715 Williams St, Cumberland, MD 21502-6390 Ph: (301) 759-3817 |
News Archive
Alnylam Pharmaceuticals, Inc. has announced that it has filed a Clinical Trial Application (CTA) with the U.K. Medicines and Healthcare products Regulatory Agency (MHRA) to initiate a Phase 1/2 clinical trial with ALN-AAT, a subcutaneously administered investigational RNAi therapeutic targeting alpha-1 antitrypsin (AAT) for the treatment of AAT deficiency-associated liver disease (alpha-1 liver disease).
Though Haiti's cholera "epidemic continues to spread, infecting more than 125,000 people and killing more than 3,200," it seems to have "stabilized in" the town of Mirebalais, which is close to the "U.N. camp of Nepalese peacekeepers who are under investigation as a possible source" of the outbreak, the Seattle Times reports in a story outlining how aid groups and health workers are dealing with the situation.
Researchers have discovered why long-term use of L-DOPA (levodopa), the most effective treatment for Parkinson's disease, commonly leads to a movement problem called dyskinesia, a side effect that can be as debilitating as Parkinson's disease itself.
Against a backdrop of growing concern about the impact of tuberculosis on children, top scientific experts today published a global plan of action for developing the vaccines that are seen as critical to eliminating the disease. Published today in a special issue of the journal, Tuberculosis , the strategic blueprint for the TB vaccine field, represents consensus reached by the TB vaccine community.
The liver filters blood, detoxifies chemicals and metabolizes drugs. Hepatitis, alcohol and primary liver diseases are common sources of damage in the liver and can result in scarring, known as fibrosis.
› Verified 4 days ago
Dr. Feiyu Hong, M.D. Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 12500 Willowbrook Rd, Cumberland, MD 21502 Phone: 240-964-7000 | |
Dr. Robustiano Jocson Barrera Jr., M.D. Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 200 Glenn Street, Suite #302, Cumberland, MD 21502 Phone: 240-522-0470 Fax: 240-522-0471 | |
Dr. James B. Deren, M.D. Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 1050 W Industrial Blvd, Cumberland, MD 21502 Phone: 240-964-9355 Fax: 240-964-9356 | |
Dr. Christopher Haas, D.O. Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 12502 Willowbrook Rd, Suite 330, Cumberland, MD 21502 Phone: 240-964-8740 | |
Sunil Kumar Gupta, MD Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 625 Kent Ave Ste 101, Cumberland, MD 21502 Phone: 301-724-7117 | |
Dr. Qamar Ul Zaman, MD Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 12502 Willowbrook Rd, Suite 440, Cumberland, MD 21502 Phone: 301-777-3111 Fax: 301-777-0963 | |
Dr. Gregg C Donaldson, MD Cardiovascular Disease Medicare: Medicare Enrolled Practice Location: 912 Seton Dr, Cumberland, MD 21502 Phone: 301-722-3111 Fax: 301-722-5135 |